Back to the library
9 min read

Beyond Blood Groups: What Genetic Factors Should Couples Know Before Marriage?

Indian families match blood groups before marriage. But the risks that cause the most preventable suffering - thalassemia, sickle cell, SMA - are silent recessive genes blood typing never catches. 40 million Indians carry the thalassemia gene and never know. Test before the wedding.

For generations, Indian families have matched blood groups before marriage. Type A to Type B, checking Rh factors, asking about any history of haemoglobin disorders. It is a ritual that feels medically responsible. And compared to knowing nothing, it is. But blood group matching is the first page of a much longer chapter. Modern genetics has given couples access to information about their reproductive future that goes far beyond blood type, and the gap between what is now knowable and what most Indian couples actually check is quietly causing preventable suffering in thousands of Indian families every year.

Why Blood Group Matching Is Not Enough

Blood group compatibility checking originated from a genuine concern: Rh incompatibility between an Rh-negative mother and an Rh-positive foetus can, in later pregnancies, cause the mother's immune system to attack the baby's red blood cells. This is a real risk, now largely manageable with antenatal Rh immunoglobulin treatment. But the genetic risks that cause the most preventable suffering in Indian families are not Rh incompatibility. They are recessive single-gene disorders where both parents must be carriers for the child to be affected, and where both carriers are completely healthy and often have no family history. You can carry the variant for thalassemia, sickle cell disease, or spinal muscular atrophy your entire life without symptoms. Without testing, you will never know. Your partner may carry the same variant without knowing. And if both of you do, each pregnancy carries a 25% chance of producing an affected child.

Thalassemia: India's Largest Hereditary Emergency

India bears a massive thalassemia burden, with over 150,000 patients living with the condition and nearly 10,000 to 12,000 new affected children born every year. An estimated 40 million Indians are carriers of the thalassemia gene, roughly 1 in 35 people. Carriers are entirely healthy and do not know they carry the gene unless specifically tested. When two carriers marry and have children, each pregnancy has a 25% chance of producing a child with thalassemia major, the severe form that requires lifelong blood transfusions every two to four weeks. Prevention is straightforward: test both partners before marriage or conception. If both are carriers, they have the full range of options, from natural conception with prenatal testing to IVF with preimplantation genetic testing (PGT-M) that can select unaffected embryos. The option exists. The knowledge must come first.

Sickle Cell Disease: Especially Critical for Specific Communities

Sickle cell disease is a hereditary condition where red blood cells form an abnormal crescent shape, causing severe pain, organ damage, anaemia, and reduced life expectancy without intensive management. Like thalassemia, it is autosomal recessive. Carrier rates are particularly high in specific tribal and community populations across Maharashtra, Gujarat, Madhya Pradesh, Odisha, Chhattisgarh, Jharkhand, and parts of Tamil Nadu and Andhra Pradesh, reaching 20 to 30 per cent in some communities. For couples from these backgrounds, sickle cell carrier testing before marriage is among the most important preventive actions they can take.

Spinal Muscular Atrophy: The Most Common Fatal Genetic Disorder in Infants

SMA is a leading genetic cause of infant mortality. It destroys the motor nerve cells that control voluntary muscle movement, including breathing and swallowing. The most severe form, SMA Type 1, is typically fatal before age two without treatment. Approximately 1 in 40 to 1 in 50 people are carriers of the SMN1 gene deletion that causes SMA. Treatment exists and works best when started in the newborn period, before symptoms develop, so knowing carrier status before conception gives couples the option of preimplantation genetic testing or arranged newborn screening.

Women's Health and Men's Health Genetics

The MatchGenes Women's Health panel covers PCOS, hereditary breast and ovarian cancer risk through BRCA1 and BRCA2, endometriosis predispositions, peripartum depression risk, osteoporosis risk, and autoimmune conditions that disproportionately affect women. 1 in 5 Indian women has PCOS, and a genetic panel can reveal whether her PCOS risk is driven by insulin resistance patterns or androgen sensitivity variants. On the men's side, male factor infertility accounts for about 50% of couple infertility, and many genetic causes are silent until conception is attempted. The MatchGenes Men's Health panel covers genetic factors relevant to male fertility, hormonal regulation, and other conditions that benefit from early awareness.

Pharmacogenomics: Medicines That May Work Differently For You

Pharmacogenomics, the study of how your genes affect your response to medication, is increasingly relevant for couples planning a family. During pregnancy, women may require medications for hypertension, thyroid conditions, depression, or gestational diabetes. How efficiently a woman metabolises these is partly genetic, and variants in drug-metabolising genes affect both the effectiveness and safety of standard dosages.

The Right Time to Test

The best time to screen is pre-pregnancy or at the first antenatal visit. But ideally, testing happens even earlier, before the wedding, because pre-marriage testing gives the longest window for decision-making. Results that arrive during early pregnancy require decisions under time pressure and emotional strain. Results before the wedding allow a calm, supported conversation with a genetic counsellor. At MatchGenes, premarital genetic testing requires only a simple saliva sample from each partner, collected at home, with both kits arriving together and results shared in a joint counselling session where a certified genetic counsellor explains every finding, the actual risk levels, and the available options.

Fast FAQ

Is genetic testing before marriage different from blood group matching?

Yes, significantly. Blood group matching addresses Rh incompatibility, now largely manageable with antenatal treatment. Pre-marital genetic testing addresses carrier status for serious inherited conditions like thalassemia, sickle cell disease, and SMA, where the stakes are much higher and where knowing before conception provides the widest range of options.

If I am a carrier, does that mean my child will definitely be affected?

No. If only one partner is a carrier, children will either be unaffected or be carriers themselves but healthy. Risk only arises when both partners carry the same variant, in which case each pregnancy carries a 25% chance of an affected child.

Which Indian communities are at highest risk?

Thalassemia carriers are found across India but are more concentrated in Sindhi, Gujarati, Punjabi, and Bengali populations. Sickle cell carrier rates are particularly high in tribal and community populations across Maharashtra, Gujarat, Madhya Pradesh, Odisha, Chhattisgarh, and Jharkhand. Testing is recommended universally regardless of background.

What happens if both of us are carriers for the same condition?

Couples can choose natural conception with prenatal diagnostic testing, IVF with preimplantation genetic testing to select unaffected embryos, donor gametes, or other family-building paths. All options benefit from knowing early.

Does premarital genetic testing need to be repeated for every pregnancy?

No. Your DNA does not change. Carrier status identified in a pre-marital panel remains relevant for every future pregnancy. What may be revisited are prenatal diagnostic tests for the specific foetus, but parental carrier screening only needs to happen once.